Braze, Inc. <BRZE.O>: UBS Raises Target Price to $32 From $28
BRZE•Related News

ABM Industries Inc <ABM.N>: UBS raises target price to $51.5 from $45
ABM•

BrenX H1 FY26 net loss narrows 18% to USD 6.09 million; operating loss improves 9% to USD 5.97 million
BRNX•

Comstock Resources, Inc. <CRK.N>: UBS Raises Target Price to $14 From $13
CRK•

10X Genomics, Inc. <TXG.O>: UBS Raises Target Price to $68 From $20
TXG•

eXoZymes selects Curia as commercial-scale manufacturing partner for NCT
EXOZ•